Breakthrough Is Coming
Though Amyotrophic Lateral Sclerosis (ALS) still only affects a proportionately small amount of the population, its effects are devastating. There is still mystery surrounding this debilitating disease as scientists are still only working with theories as they try to determine the root cause. Years of research and development have yielded little progress in finding a cure - until now.
3
year Median Life expectancy
15
New U.S. ALS
cases/day
100,000
ALS patients die/Year
$1.4 mil
End of LifE
COST/patient
Glutamate in ALS - MoA
~~~ Role of Muscular Atrophy in ALS ~~~
NBI is developing a new hypothesis on ALS.
Typically, ALS is thought to be a motor neuron disease that leads to muscular atrophy. However, several studies have found that muscular atrophy precedes motor neuron degeneration. So we are asking the question:
“Does the loss of motor function contribute to muscle atrophy” or “does muscle atrophy contribute to the loss of motor function”? In other words, “Can ALS primarily result from muscle atrophy instead of the degeneration of motor neurons?”
If so, muscular atrophy may be a potential therapeutic target. Glutamine supplementation may be a promising avenue. The attached presentation dives into this hypothesis. If you would like to partner with us in testing this hypothesis, you may try glutamine supplement and let us know of its effect in your life. If you benefit from it, please rate ⭐⭐⭐⭐⭐ the effectiveness using the link below to help us keep track. We do not sell glutamine supplements and are not sponsored by any provider of glutamine supplements.
Rate Effectiveness of Glutamine for Muscular Atrophy
RaphaLX™
Since 1962, there have been over 330 clinical studies for ALS with only two drugs approved by the FDA. The first drug, Rilutek™ was approved more than 20 years ago. It only extends life by 2-3 months. Recently the FDA approved Radicava, which was shown to slow down the disease progression for certain patients, but did not prolong lives. RaphaLX™ is different.
RaphaLX™ has shown great promise in early tests. It not only prolongs life, but in certain cases can reverse the condition. This has been demonstrated through a limited sampling of human case studies which will be verified through upcoming pilot studies and clinical trials.
News & Latest Developments
Alzheimer’s Disease Proposed Pathophysiology
